Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187499 · ClinicalTrials.gov registry record · NA
Effect of an Inhaled Corticosteroid on Airway Gene Expression in Asthma
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
NCT00187499: Completed NA study, sponsored by University of California, San Francisco.
NCT00187499 is a NA study that has completed, run by University of California, San Francisco. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00187499, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to determine whether an inhaled corticosteroid (fluticasone) alters the expression of any gene expressed in the lining of the airways of asthmatics. The study uses high density gene chips which allow the study investigators to measures all gene in the human genome. We hypothesize that this approach will identify novel genes that are affected by steroids in asthmatics.
Interventions
- DRUG Inhaled fluticasone 500 ug BID for 8 weeks
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-10 |
| Est. Completion | 2005-02 |
| Phase | NA |
What the finished NCT00187499 record still lists
NCT00187499 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Inhaled fluticasone 500 ug BID for 8 weeks is the first listed.
NCT00187499 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00187499 about?
NCT00187499 is a clinical study titled "Effect of an Inhaled Corticosteroid on Airway Gene Expression in Asthma". The purpose of this study is to determine whether an inhaled corticosteroid (fluticasone) alters the expression of any gene expressed in the lining of the airways of asthmatics. The study uses high density gene chips which allow the study investigators to measures all gene in the human genome. We hy...
What is the current status of trial NCT00187499?
This trial is currently completed. It is a NA study. The study started on 2002-10. Estimated completion is 2005-02.
What interventions are being tested in trial NCT00187499?
The interventions under investigation include: Inhaled fluticasone 500 ug BID for 8 weeks (DRUG).
Who is sponsoring clinical trial NCT00187499?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia